Search

Filters

Clear Filters
4:05 PM - 4:10 PM ET

1015 - A Cost-Effectiveness and Health Equity Analysis of Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer
Speaker: Subramanian, Kritika, MD, MS - Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
4:10 PM - 4:15 PM ET

1016 - Disease Site-Specific Risk Stratification for Acute Care Utilization In Radiation Oncology: A Large-Scale Competing Risk Analysis
Speaker: Pandey, Lavanya, BS - UCLA, Los Angeles, CA
4:15 PM - 4:20 PM ET

1017 - Relationship between Payer Organizational Stability and Radiation Oncology Treatment Timelines: A Time-Series Analysis
Speaker: Chen, William, MD - Northwell, New Hyde Park, NY
5:00 PM - 5:05 PM ET

1018 - Phase 1 Trial of CT-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for Treatment of Ultra-Central Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Speaker: D'Souza, Alden, MD, MPHS - Washington University in St. Louis School of Medicine, St Louis, MO
3:40 PM - 3:50 PM ET

102 - Multi-Institutional Development and Prospective Validation of a Vision-Language Model for Prostate MRI Segmentation and Prognostication
Speaker: King, Martin, MD, PhD - Brigham and Women's Hopsital, Boston, MA
8:15 AM - 8:20 AM ET

102 - Multi-Institutional Development and Prospective Validation of a Vision-Language Model for Prostate MRI Segmentation and Prognostication
Speaker: King, Martin, MD, PhD - Brigham and Women's Hopsital, Boston, MA
5:05 PM - 5:10 PM ET

1020 - Prospective Study of Surface Guided Radiation Therapy (SGRT) Alone or in Combination with Fiducials for Free Breathing (FB) vs. Breath Hold (BH) Stereotactic Body Radiation Therapy (SBRT) Treatments of the Lung
Speaker: Heinzerling, John, MD - Atrium Health Levine Cancer, Wake Forest School of Medicine, Southeast Radiation Oncology Group PA, Charlotte, NC
5:10 PM - 5:15 PM ET

1021 - Adebrelimab as Maintenance Therapy Following Hyperfractionated Simultaneous Integrated Boost Radiotherapy Plus Chemotherapy in Limited-Stage Small-Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Phase II Trial
Speaker: Yu, Jiayi, MD, PhD - Peking University Cancer Hospital and Institute, Beijing, Beijing
5:15 PM - 5:20 PM ET

1022 - Optimizing Nodal Target Delineation in Limited-Stage Small Cell Lung Cancer: A Large-Scale, Multi-Institutional Study
Speaker: Wang, Xiaolong, MS - Shandong Cancer Hospital and Institute, jinan, Shandong
5:20 PM - 5:25 PM ET

1023 - Induction Immunochemotherapy followed by Definitive Radiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Multicenter Study
Speaker: Wen, Junxu, MS - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong
4:35 PM - 4:45 PM ET

1024 - TP53 Mutations in Primary Breast Tumors Predict Brain Metastases: Insights from the MSK CHORD Cohort
Speaker: Lee, Victor, MD, BS - Yale New Haven Hospital, Middletown, CT
8:05 AM - 8:10 AM ET

1025 - Association of the Radiosensitivity Index with Overall Survival In Radiotherapy-Treated HER2+ and Triple-Negative Breast
Speaker: Nellore, Shivani, BS - Cleveland Clinic, Cleveland, OH